Toxic myopathy with multiple deletions in mitochondrial DNA associated with long‐term use of oral anti‐viral drugs for hepatitis B: A case study. Issue 2 (7th March 2019)
- Record Type:
- Journal Article
- Title:
- Toxic myopathy with multiple deletions in mitochondrial DNA associated with long‐term use of oral anti‐viral drugs for hepatitis B: A case study. Issue 2 (7th March 2019)
- Main Title:
- Toxic myopathy with multiple deletions in mitochondrial DNA associated with long‐term use of oral anti‐viral drugs for hepatitis B: A case study
- Authors:
- Fujii, Takayuki
Takase, Kei‐ichiro
Honda, Hiroyuki
Kawamura, Nobutoshi
Yamasaki, Ryo
Urata, Michiyo
Uchiumi, Takeshi
Iwaki, Toru
Kira, Jun‐ichi - Abstract:
- Abstract : Oral nucleoside analogs (NAs) reduce hepatitis B virus (HBV) replication by inhibiting HBV DNA polymerase. However, NAs can also affect human mitochondrial DNA (mtDNA) polymerase, which can lead to mtDNA depletion (quantitative abnormality). Indeed, several mitochondrial myopathy cases have been reported in which a reduced mtDNA copy number was induced by oral NAs for hepatitis B. Herein, we report a case of toxic myopathy with multiple mtDNA deletions (qualitative abnormality) associated with long‐term use of NAs for hepatitis B. A 68‐year‐old woman, who underwent long‐term treatment with lamivudine and adefovir for chronic hepatitis B, developed proximal muscle weakness in the four extremities. Neurological examination showed mild proximal muscle weakness and atrophy in the four extremities. Upon admission to our hospital, her blood lactate/pyruvate ratio during an aerobic exercise test was elevated. Myogenic patterns were observed in lower limb muscles on electromyographic examination. Muscle magnetic resonance imaging revealed diffuse atrophy of proximal muscles in the four extremities with no signal changes. A biopsy from the biceps brachii muscle showed an abnormally large variation in fiber size, scattered muscle fibers with decreased cytochrome c oxidase activity, and ragged‐red fibers. Analysis of mtDNA from skeletal muscle revealed no decrease in copy number but increased incidence of multiple deletions, including a deletion of 4977 base pairs (known asAbstract : Oral nucleoside analogs (NAs) reduce hepatitis B virus (HBV) replication by inhibiting HBV DNA polymerase. However, NAs can also affect human mitochondrial DNA (mtDNA) polymerase, which can lead to mtDNA depletion (quantitative abnormality). Indeed, several mitochondrial myopathy cases have been reported in which a reduced mtDNA copy number was induced by oral NAs for hepatitis B. Herein, we report a case of toxic myopathy with multiple mtDNA deletions (qualitative abnormality) associated with long‐term use of NAs for hepatitis B. A 68‐year‐old woman, who underwent long‐term treatment with lamivudine and adefovir for chronic hepatitis B, developed proximal muscle weakness in the four extremities. Neurological examination showed mild proximal muscle weakness and atrophy in the four extremities. Upon admission to our hospital, her blood lactate/pyruvate ratio during an aerobic exercise test was elevated. Myogenic patterns were observed in lower limb muscles on electromyographic examination. Muscle magnetic resonance imaging revealed diffuse atrophy of proximal muscles in the four extremities with no signal changes. A biopsy from the biceps brachii muscle showed an abnormally large variation in fiber size, scattered muscle fibers with decreased cytochrome c oxidase activity, and ragged‐red fibers. Analysis of mtDNA from skeletal muscle revealed no decrease in copy number but increased incidence of multiple deletions, including a deletion of 4977 base pairs (known as the common deletion) reflecting oxidative stress‐induced mtDNA damage. This case study indicates that long‐term oral antiviral therapy for hepatitis B can induce chronic oxidative damage to mtDNA resulting in qualitative mtDNA abnormalities and toxic myopathy. … (more)
- Is Part Of:
- Neuropathology. Volume 39:Issue 2(2019)
- Journal:
- Neuropathology
- Issue:
- Volume 39:Issue 2(2019)
- Issue Display:
- Volume 39, Issue 2 (2019)
- Year:
- 2019
- Volume:
- 39
- Issue:
- 2
- Issue Sort Value:
- 2019-0039-0002-0000
- Page Start:
- 162
- Page End:
- 167
- Publication Date:
- 2019-03-07
- Subjects:
- anti‐hepatitis B drugs -- common deletion -- mitochondrial DNA -- mitochondrial myopathy -- oxidative damage
Nervous system -- Diseases -- Periodicals
Nervous system -- Pathophysiology -- Periodicals
616.8047 - Journal URLs:
- http://www.blackwell-synergy.com/member/institutions/issuelist.asp?journal=neu ↗
http://onlinelibrary.wiley.com/ ↗ - DOI:
- 10.1111/neup.12548 ↗
- Languages:
- English
- ISSNs:
- 0919-6544
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 6081.513800
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 9742.xml